Showing 281-290 of 334 grants

Title Institution Researcher Program Duration Total Award Amount
Developing fusion therapeutics to selectively target beta cell surface receptors for treating T1D UT Southwestern Wen-hong Li Cures 01-July-2022 to 30-June-2025 $900.000,00
Acetazolamide and Tubuloglomerular Feedback in Persons with Type 1 Diabetes: A Clinical Trial University of California, San Diego Charles Ginsberg Improving Lives 01-November-2022 to 31-October-2026 $1.356.726,45
Harnessing zinc-tropic agents for targeted delivery of therapeutics to islet beta cells for preventing or treating T1D UT Southwestern Wen-hong Li Cures 01-August-2022 to 31-October-2025 $900.000,00
Novel mechanism and method to control T cell mediated autoimmunity in type 1 diabetes Case Western Reserve University Parameswaran Ramakrishnan Cures 01-June-2022 to 31-May-2026 $600.000,00
Evaluating the dose and toxicity of telaprevir in a rat model of T1D Joslin Diabetes Center Inc. Rohit Kulkarni Cures 01-June-2022 to 31-December-2025 $494.000,00
GPR75, a novel actor in beta cell regeneration New York Medical College Ercument Dirice Cures 01-April-2022 to 31-March-2026 $750.000,00
Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and Depression in Young Adults with Type 1 Diabetes Albert Einstein College of Medicine Jeffrey Gonzalez Improving Lives 01-December-2022 to 30-November-2026 $1.672.180,00
Synthetic Hydrogels for Islet Vascularization and Engraftment Georgia Tech Research Corporation Andres Garcia Cures 01-July-2022 to 30-June-2026 $563.235,05
Investigation of novel local immunomodulating strategies to enhance islet transplantation for T1D The Methodist Hospital Research Institute Alessandro Grattoni Cures 01-July-2022 to 30-June-2026 $962.995,99
Changing the T1DE: A randomized controlled trial comparing ACT to supportive diabetes counseling Duke University Rhonda Merwin Improving Lives 01-July-2022 to 30-June-2027 $2.534.224,22